Med Tech Gurus
Med Tech Gurus is a podcast dedicated to helping medical device executives stay on the leading edge of their industry. Whether you’re looking to grow your sales team, commercialize new devices, set up national accounts, or improve your clinical performances, this podcast is designed to help. Each episode features an interview with a thought leader or practitioner, discussing topics like: sales force, innovation, patient outcomes, emerging technologies, supply chain, group purchasing organizations, device launches, value analysis, biotech, and more.
info_outline
Fixing the Hidden Bottleneck in Healthcare
05/20/2026
Fixing the Hidden Bottleneck in Healthcare
Why do hospitals invest millions in clinical innovation—yet still struggle to move patients down the hall? In this episode of Med Tech Gurus, we sit down with Dr. David Crabb, emergency physician and CEO of Rovix, to explore one of healthcare’s most overlooked operational challenges: patient transport. Drawing on his dual experience in frontline emergency medicine and clinical informatics, Dr. Crabb shares how delays in moving patients between departments can quietly impact throughput, staff workload, and ultimately patient outcomes. At Rovix, Dr. Crabb is leading the development of an autonomous mobile robot designed to attach to standard hospital stretchers—safely transporting patients while reducing delays, minimizing staff injuries, and helping clinicians work at the top of their license. We discuss how physical AI and robotics are moving beyond the digital world to address real-world inefficiencies inside hospitals. From building trust in AI-driven systems to navigating adoption challenges in complex care environments, this episode explores what it takes to introduce an entirely new category of medical technology—and why solving logistical problems may be the key to unlocking better care delivery.
/episode/index/show/med-tech-gurus/id/41276055
info_outline
The Product Adoption Lie: Why Great MedTech Fails to Scale
05/13/2026
The Product Adoption Lie: Why Great MedTech Fails to Scale
Why do so many breakthrough MedTech products fail — even when the technology works? In this episode of Med Tech Gurus, we’re joined by Holley Miller, Founder and President of Grey Matter Marketing and one of the most direct, no-nonsense voices in healthcare commercialization today. With nearly three decades in life sciences — from the early days of surgical robotics to advising CEOs, boards, and investors — Holley has helped create more than $4.5 billion in enterprise value by doing one thing differently: designing adoption before launch. Holley is the architect of what she calls the Product Adoption Lie — the dangerous belief that better products automatically win. In this conversation, she explains why most launches fail not because the product is weak, but because the market was never taught to change its beliefs or behavior. We explore why adoption must be engineered, how category design replaces traditional go-to-market playbooks, and why alignment across clinical, regulatory, and commercial teams is essential to changing the standard of care. If you’re a founder, executive, or investor trying to scale innovation — not just launch a product — this episode delivers a hard truth and a clear roadmap for building something the market can’t ignore.
/episode/index/show/med-tech-gurus/id/41283750
info_outline
When Every Minute Is Critical: Scaling AI to Save Stroke Patients
05/06/2026
When Every Minute Is Critical: Scaling AI to Save Stroke Patients
What if frontline clinicians everywhere had instant access to expert-level stroke imaging — no matter where a patient arrives? In this episode of Med Tech Gurus, we’re joined by Michalis Papadakis, CEO and Co-Founder of Brainomix, an Oxford University spin-out using AI to transform how stroke is diagnosed and treated. With a background in neuroscience from Imperial College London, UCL, and the University of Oxford, Michalis built Brainomix with a singular mission: ensure patients don’t miss out on life-saving stroke treatments due to delays or lack of imaging expertise. Under his leadership, Brainomix developed Brainomix 360 Stroke, the world’s first fully automated AI imaging suite for stroke care — now deployed in more than 30 countries, backed by 50+ clinical publications, and processing patient scans in minutes with results delivered in under sixty seconds. In this conversation, we explore how starting with a true clinical unmet need, relentless evidence generation, and seamless workflow integration enabled Brainomix to scale globally and materially improve patient outcomes. If you care about AI in healthcare, stroke innovation, clinical adoption, or scaling medtech from academia to enterprise, this is a blueprint worth hearing.
/episode/index/show/med-tech-gurus/id/41173835
info_outline
From Signal to Scale: Turning MedTech Data into Growth
04/29/2026
From Signal to Scale: Turning MedTech Data into Growth
Why do so many great MedTech products stall after launch — even when the data is there? In this episode of Med Tech Gurus, we’re joined by Amy Brouhle, Vice President of Strategic Business Development at S2N Health. A former emergency department nurse turned commercialization leader, Amy brings more than 20 years of experience spanning clinical care, GPO strategy, national accounts, and MedTech growth. Her career includes senior roles at Vizient, Hillrom, and GE Healthcare, giving her a rare, end-to-end view of how innovation actually gets adopted — or stuck. At S2N Health, Amy helps MedTech companies cut through the noise of fragmented data and turn insight into action. We explore why most organizations don’t have a data problem — they have an insight problem — and how aligning sales, marketing, and strategy around the right signals can unlock utilization, accelerate adoption, and improve investor confidence. From GPO dynamics and channel strategy to AI-powered targeting, territory planning, and go-to-market execution, Amy shares practical lessons every founder and commercial leader needs to hear. If you’re trying to translate innovation into revenue and scale, this is a conversation you won’t want to miss.
/episode/index/show/med-tech-gurus/id/41055660
info_outline
From Acute Care to Continuous Care
04/22/2026
From Acute Care to Continuous Care
Why has healthcare resisted digital transformation longer than almost any other industry? In this episode of Med Tech Gurus, we’re joined by Mariano García-Valiño, four-time entrepreneur, digital health innovator, and CEO of AXENYA—recently named one of the world’s best digital health companies by Newsweek. Mariano has built, scaled, and exited billion-dollar healthcare companies by combining technology, data, and human-centered design to tackle chronic disease at scale. Mariano is also the author of Inedible, where he argues that modern healthcare is still built for acute illness, not the chronic conditions driving today’s costs and outcomes. In this conversation, we explore why software alone isn’t enough, how AI and continuous care models unlock real impact, and what it actually takes to scale health tech in complex, regulated markets. From leadership and entrepreneurship to AI-enabled care delivery, Mariano shares hard-earned lessons on building companies with both scale and purpose. If you care about digital health, healthcare transformation, or meaningful innovation, this is a conversation you won’t want to miss.
/episode/index/show/med-tech-gurus/id/40969995
info_outline
Beating the Clock: Rethinking Brain Tumor Care
04/15/2026
Beating the Clock: Rethinking Brain Tumor Care
What if the most dangerous part of brain tumor treatment isn’t the surgery… but the wait that comes after it? In this episode of Med Tech Gurus, we sit down with Dr. Michael Garcia, Chief Medical Officer and Head of Clinical Development at GT Medical Technologies, and one of the leading voices reshaping how we treat brain tumors. Dr. Garcia leads the clinical strategy behind GammaTile® — an implantable, bioabsorbable device that delivers targeted radiation from inside the brain immediately after surgery, eliminating the dangerous 3–6 week delay where tumors often begin to grow back. Under his leadership, GT Medical has reported powerful interim clinical data showing GammaTile can reduce the risk of recurrence or death by more than 50% compared to standard of care — with no increase in safety concerns. Today, more than 150 leading cancer centers are using this technology, changing not only outcomes, but something equally important: patient experience. Less anxiety. Fewer treatment delays. Fewer logistical burdens. More hope. Dr. Garcia shares the science, the strategy, and the deeply personal mission behind this innovation — along with insights on clinical trial design, multidisciplinary collaboration, and building medtech that truly serves patients. If you care about oncology, neurosurgery, innovation with purpose, or patient-centered design, this is a conversation you won’t want to miss.
/episode/index/show/med-tech-gurus/id/40878965
info_outline
Stickers That Can Save Lives: The Future of MicroWearable Health Monitoring
04/08/2026
Stickers That Can Save Lives: The Future of MicroWearable Health Monitoring
What happens when rocket-science precision meets frontline healthcare? In this episode of Med Tech Gurus, we sit down with Professor Mark Kendall, Founder & CEO of WearOptimo and one of the world’s most visionary biomedical innovators. A former rocket scientist turned medtech pioneer, Mark has already transformed vaccine delivery with groundbreaking platforms like PowderJet and Vaxxas. Now, he’s doing it again — this time with a revolutionary micro-wearable sensor designed to pull high-fidelity biosignals directly from the skin without painful needles or invasive hardware. Mark explains how WearOptimo’s sticker-like microneedle patch, built using cutting-edge manufacturing techniques that scale to tens of millions of units, is redefining what wearables can do. The first target? Hydration monitoring — solving a problem so widespread it quietly reduces life expectancy and affects elite athletes, surgical outcomes, and everyday health. From scalable manufacturing and AI-enabled biomarker intelligence, to building elite teams and navigating fundraising, Mark delivers powerful lessons on innovation, leadership, and building technologies that truly matter. If you’re passionate about the future of wearable medicine, platform technology, and designing solutions that actually reach the real world, this conversation is one you won’t want to miss.
/episode/index/show/med-tech-gurus/id/40764195
info_outline
From Data to Decisions: Powering Growth in MedTech
04/01/2026
From Data to Decisions: Powering Growth in MedTech
What if getting breakthrough devices to the right patients wasn’t a guessing game — but a data-driven science? In this episode of Med Tech Gurus, we sit down with Mike Monovoukas, CEO and Co-Founder of AcuityMD, one of the fastest-growing platforms in MedTech. Mike shares how his team is turning mountains of messy healthcare data into clear, actionable insights — helping innovators pinpoint the right physicians, facilities, and patient populations, and transforming how devices reach the people who need them most. We explore how AcuityMD is powering precision targeting through AI, why democratizing market intelligence helps level the playing field for new entrants, and how smarter commercialization can unlock access for underserved communities — including their work helping EPI bring the Alpha-Stim device to veterans struggling with pain, insomnia, and anxiety. From designing platforms built specifically for MedTech, to making complex data simple for frontline sales teams, to reshaping how companies scale, Mike delivers a masterclass in building for the future of commercialization — where evidence, empathy, and AI come together.
/episode/index/show/med-tech-gurus/id/40689850
info_outline
Why Patients Are Losing Trust in Healthcare | The MAHA Signal Explained
03/25/2026
Why Patients Are Losing Trust in Healthcare | The MAHA Signal Explained
What if the Make America Healthy Again (MAHA) movement isn’t political noise—but a powerful signal that patient expectations are fundamentally changing? In this episode of Med Tech Gurus, we sit down with Noël Theodosiou, CEO of Luminous, to explore the growing trust gap between life sciences companies and the patients they serve. Noël challenges leaders to move beyond a traditional “we know best” mindset and embrace a biopsychosocial, patient-centered approach to innovation. From GLP-1 adoption trends to AI-driven health searches, we discuss why co-creation, prevention, and clearer separation between science and promotion are critical to rebuilding credibility. For founders, executives, and investors navigating today’s shifting healthcare landscape, this conversation delivers practical insight into aligning innovation with modern patient expectations.
/episode/index/show/med-tech-gurus/id/40615570
info_outline
The Future of Stroke Care Starts Here
03/18/2026
The Future of Stroke Care Starts Here
In this episode of Med Tech Gurus, we sit down with Dr. Adam S. Arthur, Chief Medical Officer for Medtronic’s Neurovascular business — and one of the most influential voices in modern stroke care. With more than 20 years as a practicing neurosurgeon, clinical researcher, and academic leader, Dr. Arthur has helped redefine standards of care for ischemic stroke, hemorrhagic stroke, carotid disease, and neurovascular innovation worldwide. Now at Medtronic, he’s leading the charge to translate real-world clinical insight into breakthrough devices that scale — from next-generation thrombectomy tools to new applications for established technologies like Onyx, and a pipeline of neurostimulation, robotics, and endovascular therapies that promise to change what’s possible for brain health. Dr. Arthur shares powerful lessons from decades of clinical trials, including why “the devil is in the details,” how honest collaboration between physicians and industry accelerates innovation, and why failing fast is often the quickest path to breakthroughs. He also offers an exciting look at the future: remote robotics, closed-loop vagus nerve stimulation, and new ways to reach stroke patients with life-saving precision. If you care about the future of stroke care, neurovascular devices, or scaling innovation responsibly, this episode delivers a masterclass from one of the field’s true thought leaders.
/episode/index/show/med-tech-gurus/id/40516540
info_outline
Engineering the Future of Wearables
03/11/2026
Engineering the Future of Wearables
In this episode of Med Tech Gurus, we’re joined by John Dugas and Dr. Kevin Schwarz of Solventum Medical—two leaders pushing wearable innovation into its next era. With expertise spanning chemical engineering, materials science, synthetic biology, and global R&D, John and Kevin show how truly breakthrough wearables demand far more than clever sensors. They require world-class adhesives, smart overlays, skin-friendly materials, and device designs that survive real life—not just the lab. They explain why longer wear time is becoming one of the biggest drivers of clinical success, how thin-film overlays can quadruple device survivability, and why understanding patient behavior is just as important as engineering excellence. From global scale to skin biomechanics, this episode delivers a powerful look at what it really takes to build wearables that stay on, stay comfortable, and stay effective. If you’re building the next generation of chronic disease tools, diagnostics, or connected care devices — this conversation is packed with insights you won’t want to miss.
/episode/index/show/med-tech-gurus/id/40389595
info_outline
Cracking the Code on Back Pain
03/04/2026
Cracking the Code on Back Pain
In this episode of Med Tech Gurus, we welcome Neil Klompas, Chief Executive Officer of Augurex Life Sciences. With more than two decades of experience leading companies at the intersection of diagnostics, rheumatology, and translational medicine, Neil is pioneering a new era of autoimmune biomarker discovery. Under his leadership, Augurex developed SpineStat, the world’s first blood test designed to identify axial spondyloarthritis (AxSpA)—a chronic inflammatory spinal disease that affects millions yet often goes undiagnosed for nearly a decade. By leveraging the anti-14-3-3η autoantibody in combination with CRP, SpineStat is helping clinicians detect disease earlier, prevent irreversible spinal damage, and even reduce opioid dependence through faster, targeted treatment. Neil shares how engaging early with regulators helped Augurex earn FDA Breakthrough Device Designation, why he believes rheumatology is poised for its “oncology moment,” and how keeping his team centered on the patient journey drives innovation every day. If you’re passionate about precision diagnostics, regulatory navigation, and building mission-driven teams, this episode is a masterclass in turning unmet medical need into measurable clinical impact.
/episode/index/show/med-tech-gurus/id/40308630
info_outline
The Human Side of MedTech Security
02/25/2026
The Human Side of MedTech Security
What if the next medical breakthrough could be undone—not by biology—but by a hacker? In this episode of Med Tech Gurus, we sit down with Christian Espinosa, CEO and Founder of Blue Goat Cyber, a leading medical device cybersecurity consultancy helping innovators protect patients by securing the technology behind modern healthcare. With over 30 years of experience spanning the U.S. Air Force, Department of Defense, and MedTech industry, Christian brings a rare perspective on precision, resilience, and empathy in cybersecurity After a personal health scare revealed vulnerabilities in his own implanted device, Christian turned mission into movement—founding Blue Goat Cyber to transform cybersecurity from a regulatory afterthought into a strategic advantage Christian shares how patient safety—not data protection—must be the heart of every cybersecurity strategy, why “bolting on” security late in development can derail innovation, and how emotional intelligence drives his leadership in high-stakes medtech environments. Whether you’re a startup founder, RA/QA leader, or healthcare executive, this episode delivers powerful lessons on building trust, protecting patients, and creating a culture where security saves lives.
/episode/index/show/med-tech-gurus/id/40220255
info_outline
Predicting the Unseen: AI That Saves Lives
02/18/2026
Predicting the Unseen: AI That Saves Lives
What if artificial intelligence could spot hospital-acquired infections days before symptoms appear? In this episode of Med Tech Gurus, we sit down with Benedikt von Thüngen, CEO and Co-Founder of Sanome, a company redefining hospital care through AI-powered clinical decision support. After enduring profound personal and professional loss, including the collapse of his seed round and the death of loved ones, Benedikt rebuilt his company around one mission—helping clinicians understand patients earlier and intervene faster Under his leadership, Sanome became the first UK-based AI company to earn Class IIb certification for HAI prediciton. Its Memory Platform predicting infections up to 72 hours sooner than conventional methods with the potential to save each NHS Trust over £1.1 million per year. Benedikt shares a powerful story of resilience, transparency, and innovation—proving that when data, determination, and purpose align, technology can truly save lives.
/episode/index/show/med-tech-gurus/id/40147990
info_outline
Connected Care, Safer Births
02/11/2026
Connected Care, Safer Births
What if the key to saving lives in maternal health wasn’t more hospital visits—but smarter, connected care at home? In this episode of Med Tech Gurus, we sit down with Anish Sebastian, Co-Founder and CEO of BabyScripts, the leading virtual care platform transforming how mothers and providers navigate pregnancy. Built from both analytics and empathy, BabyScripts bridges one of healthcare’s most critical gaps—access to consistent, quality prenatal and postpartum care Under Anish’s leadership, BabyScripts has raised over $30 million in funding from partners like Philips and Cigna, now managing over 300,000 pregnancies across more than 70 health systems. From detecting preeclampsia early to supporting mental health and postpartum recovery, the platform delivers measurable results—proving that technology and teamwork can make pregnancy safer for every mother. Anish shares his insights on scaling digital health, building strategic partnerships, and leveraging AI to expand maternal care equity. Whether you’re an entrepreneur, innovator, or clinician, this episode reveals how connected technology can deliver life-changing outcomes at scale.
/episode/index/show/med-tech-gurus/id/40069780
info_outline
Beating Cancer with Precision
02/04/2026
Beating Cancer with Precision
What if we could take the guesswork out of cancer treatment—and move from try and hope to test and know? In this episode of Med Tech Gurus, we sit down with Jim Foote, CEO and Founder of First Ascent Biomedical, whose mission began after losing his son to cancer. That experience became the driving force behind Functional Precision Medicine (FPM)—a groundbreaking approach that combines tumor testing, genomics, and AI to rank the most effective drugs for each patient in just ten days Backed by a Nature Medicine study showing an 83% patient benefit rate, First Ascent is proving that personalization saves lives. With automation reducing lab times from hours to minutes and new CLIA-certified labs accelerating access, Jim and his team are reshaping how cancer care is delivered. From building trust with clinicians to leading through loss, Jim shares a powerful story of innovation, resilience, and purpose that every medtech leader can learn from.
/episode/index/show/med-tech-gurus/id/39984340
info_outline
Saving Lives with Simpler Trauma Care
01/28/2026
Saving Lives with Simpler Trauma Care
What if trauma care didn’t require a full surgical team or a giant toolbox to save lives in critical moments? In this episode of Med Tech Gurus, Dr. Adam Power, vascular surgeon and co-founder of Frontline Medical Technologies, takes us inside the development of the COBRA-OS—an ultra-simplified REBOA device that’s transforming trauma care. From war zones to rural communities, Dr. Power explains how miniaturization and smart design make this innovation faster, safer, and more accessible—without sacrificing patient outcomes. We discuss the challenges of commercialization, academic innovation, and the evolving role of physicians as entrepreneurs. Gurus, this episode is a masterclass in turning front-line insight into global impact. Don’t miss it!
/episode/index/show/med-tech-gurus/id/39905385
info_outline
Stress as the Sixth Vital Sign: Precision Medicine at Scale
01/21/2026
Stress as the Sixth Vital Sign: Precision Medicine at Scale
What if the missing link in treating autoimmune disease wasn’t a new drug—but a better way to measure stress? In this episode of Med Tech Gurus, we sit down with Dr. Andrew Holman, CEO of Inmedix and the innovator behind CloudHRV, the first FDA-cleared platform to measure stress biology with medical-grade precision .At a time when 75% of autoimmune treatments fail—costing billions and leaving patients without answers—CloudHRV delivers actionable insights in just five minutes reframing how clinicians think about chronic disease. Dr. Holman takes us inside his two-decade journey building Inmedix, from early IP strategy to securing partnerships with global pharma. Along the way, he shares lessons on leveraging licensing as a growth strategy, building a culture of innovation, and aligning science, business, and patient care in the pursuit of transformative healthcare solutions. Whether you’re a founder, investor, or clinician, this conversation will reshape how you think about precision medicine and the future of patient-centered innovation.
/episode/index/show/med-tech-gurus/id/39813170
info_outline
From Patents to Patients: Reinventing Arterial Treatment
01/14/2026
From Patents to Patients: Reinventing Arterial Treatment
What happens when one of the toughest challenges in vascular medicine—severe arterial calcification—meets breakthrough engineering? In this episode of Med Tech Gurus, we sit down with Dr. Robert Chisena, Co-Founder and CTO of Amplitude Vascular Systems (AVS). With a PhD in mechanical engineering and a portfolio of five patents, Robert has dedicated his career to tackling one of the most stubborn barriers in cardiovascular health: hardened arterial blockages that resist traditional interventions. From the labs at the University of Michigan to the founding of AVS, Robert shares how he and his team are developing a next-generation intravascular lithotripsy platform designed to fracture calcium safely and effectively—combining the familiarity of angioplasty with the power of shockwave technology. Along the way, he offers lessons on building IP-rich startups, fostering innovation cultures, securing clinical adoption, and navigating the high-stakes path from spinout to commercialization Whether you’re an engineer, entrepreneur, or investor in medtech, this conversation shines a light on the strategies, setbacks, and breakthroughs required to transform a complex clinical challenge into a scalable, life-saving solution.
/episode/index/show/med-tech-gurus/id/39721630
info_outline
Restoring Dignity: Wearable Neuromodulation at Home
01/07/2026
Restoring Dignity: Wearable Neuromodulation at Home
What if solving a widespread medical condition didn’t require surgery, expensive implants, or harsh medications—but could be done by simply putting on a sock? In this episode of Med Tech Gurus, we sit down with Isaac Oppenheim, CEO and Founder of Zida, a company pioneering wearable neuromodulation at the intersection of aging, textiles, and healthcare. Inspired by his grandfather’s struggle with overactive bladder (OAB), Isaac developed the Zida Control Sock—the first FDA-cleared, Medicare-covered, home-use neuromodulation device for OAB. From his early career in textiles and wearable tech with brands like Nike and Lululemon, to navigating FDA clearance and CMS reimbursement without institutional capital, Isaac’s journey shows what happens when design thinking, perseverance, and patient-centered innovation come together. Clinical trials show nearly 80% success rates, giving millions of patients renewed confidence, independence, and quality of life Whether you’re an entrepreneur building medtech from scratch, a clinician seeking better therapies for aging populations, or an innovator curious about the future of neuromodulation, this episode is packed with lessons on resilience, creativity, and making healthcare more human.
/episode/index/show/med-tech-gurus/id/39635485
info_outline
From Innovation to Impact: The Value-Based Playbook
12/17/2025
From Innovation to Impact: The Value-Based Playbook
What happens when groundbreaking medtech isn’t enough—when success depends on how well physicians and health plans actually adopt it? In this episode of Med Tech Gurus, we sit down with Dr. Shannon Decker, PhD, MBA, M.Ed., Founder & CEO of VBC1. With over 25 years of experience in healthcare transformation—including 17 years in Medicare, Medicaid, quality improvement, and risk adjustment—Shannon has become a nationally recognized strategist on aligning medical devices with real-world provider workflows. From helping health plans and physician groups improve outcomes, to showing medtech innovators why the best devices still fail without strong provider enablement, Shannon shares hard-earned lessons on education, incentives, and adoption. She explains how startups can avoid costly mistakes, when to engage with clinicians, and why intrinsic motivation often drives lasting change more than financial incentives. Whether you’re a startup CEO, a commercial leader, or a clinician navigating the shift to value-based care, this conversation delivers a playbook for turning innovation into impact
/episode/index/show/med-tech-gurus/id/39435765
info_outline
When Innovation Meets the Human Heart
12/10/2025
When Innovation Meets the Human Heart
What if the lines of code you wrote weren’t just running a program—but keeping someone’s heart beating? In this episode of Med Tech Gurus, we sit down with Wade Demmer, Vice President of Research and Development for Cardiac Pacing Therapies at Medtronic, whose career journey began with his grandmother’s pacemaker and led him to help pioneer some of the world’s most impactful cardiac devices, including Micra, the world’s smallest pacemaker. Wade shares the lessons of two decades inside the world’s largest medtech company—what it really takes to build a culture of innovation, engineer for reliability, and launch breakthrough devices at scale. From balancing patient safety with bold ideas, to recognizing when timing makes or breaks a technology, Wade brings a deeply personal and practical lens to the future of cardiac pacing and medtech innovation. Whether you’re an engineer, entrepreneur, or leader aiming to improve patients’ lives, this conversation will expand how you think about risk, collaboration, and building technologies that truly matter
/episode/index/show/med-tech-gurus/id/39351700
info_outline
Sharper Vision, Smarter Tools
12/03/2025
Sharper Vision, Smarter Tools
What happens when decades-old surgical tools finally get a 21st-century upgrade? In this episode of Med Tech Gurus, we sit down with Andy Chang, Chief Commercial Officer at BVI, to explore how innovation is reshaping ophthalmology. Andy takes us behind the launch of Leos, a next-generation glaucoma laser platform designed to be faster, smarter, and more intuitive—giving surgeons precision while saving valuable OR time. Drawing on his global commercialization experience with leaders like Zeiss and Bausch & Lomb, Andy shares what it really takes to scale disruptive technologies: from designing surgeon-friendly tools that blend seamlessly into workflows, to balancing veteran expertise with fresh ideas on commercial teams, to building feedback loops that keep patients at the center of every decision. Whether you’re an innovator introducing new platforms, a commercial leader navigating global markets, or a clinician eager to see where eye care is headed, this episode delivers sharp insights on strategy, leadership, and the future of ophthalmic innovation. #MedTech #Ophthalmology #Glaucoma #HealthcareInnovation #MedicalDevices #SurgicalInnovation #VisionCare
/episode/index/show/med-tech-gurus/id/39248005
info_outline
Local Care, Virtually Anywhere
11/26/2025
Local Care, Virtually Anywhere
In an era where telehealth is often reduced to quick, one-off visits, Ovatient CEO Michael Dalton is charting a different course—one that blends digital access with the trust, continuity, and whole-person focus of traditional care. With deep roots inside health systems like MetroHealth and MUSC, Michael shares how Ovatient was built “by health systems, for health systems” to move beyond transactional virtual care. He reveals the keys to building trust in digital health, integrating seamlessly with Epic, and creating true partnerships rather than vendor relationships. From reducing barriers for patients to scaling integrated behavioral health, Ovatient’s model is showing how virtual-first can still be personal, local, and outcome-driven. You’ll hear real patient stories, lessons on co-developing with health systems, and strategies for delivering high-quality care at scale—without losing the human touch. Whether you’re a health system leader, digital health innovator, or investor, this conversation is packed with insights on designing virtual care models that last, scale, and truly serve
/episode/index/show/med-tech-gurus/id/39173005
info_outline
The Science Whisperer: How to Speak VC, Clinician & Regulator
11/19/2025
The Science Whisperer: How to Speak VC, Clinician & Regulator
What happens when a medtech founder starts college at 12, launches their first company at 9, and grows up to help clients secure over $1 billion in funding? You get Elizabeth Chabe, CEO of High Touch Group. In this episode of Med Tech Gurus, Elizabeth shares how she helps science-driven companies translate complex innovations into stories that resonate with investors, regulators, and clinicians. She offers powerful insights on breaking past “no,” avoiding costly early-stage mistakes, and navigating today’s funding challenges with creative, non-dilutive strategies. If you’re struggling to get your technology off the ground—or into the right hands—Elizabeth’s wisdom and practical guidance will help you turn complexity into commercial clarity. Don’t miss this one!
/episode/index/show/med-tech-gurus/id/39091110
info_outline
Faster, Smarter, Virtual Heart Care
11/12/2025
Faster, Smarter, Virtual Heart Care
Every minute counts in cardiology—but for too many patients, the wait to see a specialist is measured in weeks. In this episode of Med Tech Gurus, Dr. Jeff Wessler, cardiologist and CEO of Heartbeat Health, shares how his team is transforming heart care with a virtual-first model. By combining telehealth, remote diagnostics, and evidence-based protocols, Heartbeat Health is tackling one of medicine’s most urgent challenges: delivering timely, life-saving cardiac care to patients wherever they are. Dr. Wessler takes us inside the evolution of Heartbeat Health—from its origins in New York to its nationwide impact. He explains how virtual-first cardiology is closing critical access gaps, how remote monitoring and cloud-based “clinics” can prevent emergencies, and why building a culture of innovation and rigorous outcomes tracking has been key to their success. If you’re passionate about digital health, virtual care, or improving patient outcomes, this episode is packed with insights on what it takes to scale a new standard of care.
/episode/index/show/med-tech-gurus/id/39000120
info_outline
Where AI Meets Early Detection—and Patients Win
11/05/2025
Where AI Meets Early Detection—and Patients Win
When it comes to serious illness, early detection can be the difference between a difficult battle and a manageable path forward. But what if advanced diagnostics didn’t require a referral, radiation, or even a reason to feel sick? In this episode of Med Tech Gurus, we sit down with Mike Wernli, Chief Operating Officer at Craft Health, to explore how they’re flipping the script on traditional healthcare. With AI-enhanced full-body MRI scans, Craft Health is delivering hospital-grade insights in under 30 minutes—without contrast or complexity. But the technology is only part of the story. Mike opens up about the mindset shift required to empower patients to take control of their health before symptoms appear. He shares how Craft is combining clinical excellence with retail-like access, building a culture that thrives on purpose, and engaging communities in ways that truly matter. Whether you're an innovator in preventive care, a startup leader navigating consumer health, or someone passionate about shifting care upstream—this conversation offers both inspiration and a playbook.
/episode/index/show/med-tech-gurus/id/38920300
info_outline
Heart Health, Anywhere - with CorVista
10/29/2025
Heart Health, Anywhere - with CorVista
What if diagnosing coronary artery disease, pulmonary hypertension, and heart failure didn’t require a hospital, a specialist, or even invasive testing? In this episode, Adrian Lam, CEO of Corvista Health, shares how their FDA-cleared, AI-powered platform is transforming frontline cardiac care—delivering accurate, non-invasive diagnostics in under 30 minutes. Adrian discusses the delicate balance of explainable AI, clinical trust, and business strategy. He also dives into lessons on IP protection, clinical validation, and why understanding unmet needs—both clinical and operational—is key to commercial success. From rural health access to drug monitoring and phenotypic insights, this episode is packed with lessons for medtech entrepreneurs, investors, and innovators alike.
/episode/index/show/med-tech-gurus/id/38815925
info_outline
The Silent Guardian: Scaling Innovation for Global IV Safety
10/22/2025
The Silent Guardian: Scaling Innovation for Global IV Safety
What if a discreet sensor could quietly prevent one of healthcare’s most common—and dangerous—IV injuries? In this episode of Med Tech Gurus, Jaclyn Lautz Ph.D., COO of IV Watch, takes us inside the journey of building a global standard of care. Jaclyn shares how her team navigated the EU MDR maze, achieved regulatory approvals across 16 countries, and proved their technology’s impact through powerful clinical studies. From mentoring moments that shaped her career to the operational discipline driving IV Watch’s innovation, this conversation delivers invaluable insights for MedTech leaders aiming to scale globally while keeping patient safety at the core.
/episode/index/show/med-tech-gurus/id/38730665
info_outline
When Seconds Count: Reinventing Airway Management
10/15/2025
When Seconds Count: Reinventing Airway Management
What if a simple design shift could save lives in the most chaotic environments? In this episode of Med Tech Gurus, Dr. Irena King, neuroscientist, engineer, and CEO of Surgicure Technologies, shares how she’s transforming emergency airway management with the Horseshoe—a novel device born out of battlefield necessity and refined through deep clinical collaboration. Irena reveals the hard lessons of product design, the power of listening to frontline providers, and the importance of adapting for both civilian and military use. From trauma bays to transport units, this episode is a masterclass in building devices that work when seconds—and lives—are on the line.
/episode/index/show/med-tech-gurus/id/38588160